Hereditary hemochromatosis is a genetic disorder that promotes increased intestinal absorption and progressive tissue deposition of iron resulting in cirrhosis of the liver, hepatic carcinoma, congestive heart failure, endocrinopathies and premature death. It is estimated that 1 in 200-to-400 people in the US are homozygous for this disease which is the most common defective genetic trait known in humans, more prevalent than cystic fibrosis, phenylketonuria and muscular dystrophy combined. Iron assimilation is a tightly regulated process that is limited to prevent harmful effects due to overload of this toxic metal and therefore a reciprocal relationship exists between body iron stores and dietary iron absorption, although the molecular basis for ion homeostasis remains unknown. Many studies of the molecular basis for hemochromatosis have evaluated the expression of factors involved in iron metabolism , including transferrin, transferrin receptor, ferritin and IRPs, but strong evidence to support their abnormal regulation in this disease is lacking. We recently identified SFT (Stimulator of Fe Transport) as a facilitator of non-transferrin-bound iron uptake. Our preliminary results demonstrate that SFT expression is down- regulated at both the mRNA and protein level in response to iron-loading. However, in the course of these studies, we made the significant discovery that SFT mRNA is 5-fold higher in liver from hemochromatosis patients despite the deposition of iron that occurs in this tissue. Thus, our working hypothesis is that malregulated expression of SFT contributes to the etiology of hemochromatosis. The proposed research will specifically evaluate our hypothesis through the following goals: 1) determination of SFT activity in iron transport by hepatocytes and intestinal enterocytes; 2) examination of interactions of interactions with the hemochromatosis protein Hfe that may modulate SFT expression and function in these cells; and 3) characterization of the mechanism that regulates SFT expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK056160-01
Application #
2885728
Study Section
Nutrition Study Section (NTN)
Program Officer
Doo, Edward
Project Start
1999-09-15
Project End
2004-08-31
Budget Start
1999-09-15
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Nutrition
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Deb, Suman; Johnson, Erin E; Robalinho-Teixeira, Raquel L et al. (2009) Modulation of intracellular iron levels by oxidative stress implicates a novel role for iron in signal transduction. Biometals 22:855-62
Chlosta, Sabine; Fishman, Douglas S; Harrington, Lynne et al. (2006) The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect Immun 74:3065-7
Yin, Jun; Lin, Alison J; Buckett, Peter D et al. (2005) Single-cell FRET imaging of transferrin receptor trafficking dynamics by Sfp-catalyzed, site-specific protein labeling. Chem Biol 12:999-1006
Knutson, Mitchell D; Oukka, Mohamed; Koss, Lindsey M et al. (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci U S A 102:1324-8
Chung, Jayong; Prohaska, Joseph R; Wessling-Resnick, Marianne (2004) Ferroportin-1 is not upregulated in copper-deficient mice. J Nutr 134:517-21
Chung, Jayong; Haile, David J; Wessling-Resnick, Marianne (2004) Copper-induced ferroportin-1 expression in J774 macrophages is associated with increased iron efflux. Proc Natl Acad Sci U S A 101:2700-5
Robb, Aeisha D; Ericsson, Maria; Wessling-Resnick, Marianne (2004) Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies. Am J Physiol Cell Physiol 287:C1769-75
Knutson, Mitchell; Menzies, Sharon; Connor, James et al. (2004) Developmental, regional, and cellular expression of SFT/UbcH5A and DMT1 mRNA in brain. J Neurosci Res 76:633-41
Brown, Jing Xu; Buckett, Peter D; Wessling-Resnick, Marianne (2004) Identification of small molecule inhibitors that distinguish between non-transferrin bound iron uptake and transferrin-mediated iron transport. Chem Biol 11:407-16
Robb, Aeisha; Wessling-Resnick, Marianne (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104:4294-9

Showing the most recent 10 out of 13 publications